Optimind Pharma Corp.
OMND
CNSX
05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -27.82% | 175.36% | 210.17% | 45.02% | -50.32% |
Total Receivables | 18.30% | -60.85% | -61.96% | -50.97% | -62.86% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -15.81% | -25.02% | -15.05% | -24.18% | -54.32% |
|
|||||
Total Current Assets | -15.81% | -25.02% | -15.05% | -24.18% | -54.32% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -12.79% | -20.97% | -74.22% | -75.64% | -77.87% |
|
|||||
Total Accounts Payable | -52.66% | -41.85% | 24.01% | 342.79% | 359.35% |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -4.78% | -5.94% | -78.68% | -77.03% | -76.22% |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -39.95% | -29.60% | -62.64% | -57.49% | -25.21% |
|
|||||
Total Current Liabilities | -39.95% | -29.60% | -62.64% | -57.49% | -25.21% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -4.78% | -5.94% | -78.68% | -77.03% | -76.22% |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -39.95% | -29.60% | -63.12% | -62.09% | -33.83% |
|
|||||
Common Stock & APIC | 5.22% | -0.35% | 14.31% | 18.37% | 10.96% |
Retained Earnings | -1.57% | 1.74% | -17.94% | -25.08% | -27.98% |
Treasury Stock & Other | -0.76% | -6.02% | -3.17% | 0.25% | -0.42% |
Total Common Equity | 69.64% | 45.43% | -140.76% | -117.92% | -156.33% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 69.64% | 45.43% | -140.76% | -117.92% | -156.33% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 69.64% | 45.43% | -140.76% | -117.92% | -156.33% |
|